Arcutis grants 269,000 RSUs, 70,000 stock options to new hires under inducement plan

Arcutis Biotherapeutics

Arcutis Biotherapeutics

ARQT

0.00
  • Arcutis Biotherapeutics granted 269,000 restricted stock units plus stock options for 70,000 shares to 40 newly hired employees, with a May 1, 2026 grant date.
  • Restricted stock units vest over four years, with 25% vesting on each annual anniversary, subject to continued employment.
  • Stock options vest over four years, with 25% vesting at year one, remainder vesting monthly over next three years; options carry a 10-year term.
  • Exercise price set at USD 23.35 per share.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Arcutis Biotherapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605081600PRIMZONEFULLFEED9716171) on May 08, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.